INTERVIEW: Russia opts for strict approach in evolving regulatory landscape
This article was originally published in Clinica
Executive Summary
The government of Russia is in the midst of developing a system that will regulate medical devices properly for the first time. A mix of former Soviet and modern day concepts, it errs more towards the US FDA than the EU approach. But there are major business opportunities among the challenges, Alexandra Tretiakova, executive director of Moscow-based medical devices association IMEDA, tells Ashley Yeo
You may also be interested in...
Deadline Reprieve Mooted For Russian Registration Replacements
Medtech companies are being warned that if they do not renew their registration certificates in Russia by the start of 2017, their certificates will become invalid.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.